These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17618251)

  • 21. Minority report.
    Wallis L
    Nurs Stand; 2003 Jan 29-Feb 4; 17(20):16-7. PubMed ID: 12629879
    [No Abstract]   [Full Text] [Related]  

  • 22. Factors influencing the participation of gastroenterologists and hepatologists in clinical research.
    Dev AT; Kauf TL; Zekry A; Patel K; Heller K; Schulman KA; McHutchison JG
    BMC Health Serv Res; 2008 Oct; 8():208. PubMed ID: 18842135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applicability of NINDS-sponsored studies to community-based physician involvement.
    Lindblad AS; Clemons T; Lindblad RW; Sykes R; Meador KJ; Odenkirchen JC; Hart RG
    Neurology; 2008 May; 70(19):1688-90. PubMed ID: 18057316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial letter.
    Larkey L
    Contemp Clin Trials; 2005 Dec; 26(6):611. PubMed ID: 16271519
    [No Abstract]   [Full Text] [Related]  

  • 25. Women abound in NIH trials.
    Holden C
    Science; 2008 Oct; 322(5899):219. PubMed ID: 18845746
    [No Abstract]   [Full Text] [Related]  

  • 26. Bringing cures to all patients: addressing diversity in clinical trials.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):5-6. PubMed ID: 17824541
    [No Abstract]   [Full Text] [Related]  

  • 27. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.
    Colon-Otero G; Smallridge RC; Solberg LA; Keith TD; Woodward TA; Willis FB; Dunn AN
    Cancer; 2008 Feb; 112(3):447-54. PubMed ID: 18085590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

  • 29. Health care disparity: an overlooked problem in phase I oncology trials.
    O'Brien TE
    J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
    [No Abstract]   [Full Text] [Related]  

  • 30. It's time to reappraise recruitment of South Asians to clinical trials.
    Gammon BD; Gunarathne A
    BMJ; 2008 Jan; 336(7634):46. PubMed ID: 18174601
    [No Abstract]   [Full Text] [Related]  

  • 31. Increasing the participation: another factor.
    Sabri AA; Qayyum MA
    PLoS Med; 2006 May; 3(5):e250. PubMed ID: 16719555
    [No Abstract]   [Full Text] [Related]  

  • 32. Flaunting the feminine side of research studies.
    Greenberger P
    Science; 2008 Nov; 322(5906):1325-6. PubMed ID: 19039120
    [No Abstract]   [Full Text] [Related]  

  • 33. Patient page. Do enough women and minorities take part in drug studies for neurologic diseases?
    Smyth KA
    Neurology; 2011 Jan; 76(4):e16-7. PubMed ID: 21263133
    [No Abstract]   [Full Text] [Related]  

  • 34. Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.
    Aristizabal P
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28296. PubMed ID: 32343877
    [No Abstract]   [Full Text] [Related]  

  • 35. Add fun and profits to your practice: do research.
    Grandinetti DA
    Med Econ; 1997 Dec; 74(25):67-8, 70-4, 79. PubMed ID: 10175868
    [No Abstract]   [Full Text] [Related]  

  • 36. Comorbidity as a focus of clinical cancer trials: an important unmet need.
    Markman M
    Oncology; 2007; 73(5-6):279-80. PubMed ID: 18477852
    [No Abstract]   [Full Text] [Related]  

  • 37. Disparities in participation in cancer clinical trials.
    Bjarnason NH
    JAMA; 2004 Aug; 292(8):922; author reply 922-3. PubMed ID: 15328321
    [No Abstract]   [Full Text] [Related]  

  • 38. Financial remuneration for clinical and behavioral research participation: ethical and practical considerations.
    Permuth-Wey J; Borenstein AR
    Ann Epidemiol; 2009 Apr; 19(4):280-5. PubMed ID: 19230712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unabated increases in trial costs reflect evolving research milieu.
    Samson K
    Ann Neurol; 2009 Apr; 65(4):A9-11. PubMed ID: 19399857
    [No Abstract]   [Full Text] [Related]  

  • 40. Diversity Gains Seen in Clinical Trials.
    Cancer Discov; 2023 Dec; 13(12):2494-2495. PubMed ID: 37795980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.